Skip to main content
Journal cover image
Management of Acute Decompensated Heart Failure

Inotropes and other new therapies for acute heart failure

Publication ,  Chapter
Felker, GM; Gheorghiade, M
January 1, 2005

In this context, this chapter reviews the current understanding of the role of positive inotropic agents in the management of ADHF. Understanding the role of pharmacologic therapies for AHF requires an appreciation of the appropriate goals of therapy for this complex patient population. The term acute heart failure broadly defines a heterogeneous patient population-ranging from patients with myocardial ischemia and acute pulmonary edema to those with worsening of volume overload in the setting of chronic heart failure. Importantly, up to 40% of patients with ADHF may have preserved systolic function, which may require unique therapeutic approaches.8.

Duke Scholars

DOI

ISBN

9781841843742

Publication Date

January 1, 2005

Start / End Page

339 / 348
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Felker, G. M., & Gheorghiade, M. (2005). Inotropes and other new therapies for acute heart failure. In Management of Acute Decompensated Heart Failure (pp. 339–348). https://doi.org/10.4324/9780203421345-30
Felker, G. M., and M. Gheorghiade. “Inotropes and other new therapies for acute heart failure.” In Management of Acute Decompensated Heart Failure, 339–48, 2005. https://doi.org/10.4324/9780203421345-30.
Felker GM, Gheorghiade M. Inotropes and other new therapies for acute heart failure. In: Management of Acute Decompensated Heart Failure. 2005. p. 339–48.
Felker, G. M., and M. Gheorghiade. “Inotropes and other new therapies for acute heart failure.” Management of Acute Decompensated Heart Failure, 2005, pp. 339–48. Scopus, doi:10.4324/9780203421345-30.
Felker GM, Gheorghiade M. Inotropes and other new therapies for acute heart failure. Management of Acute Decompensated Heart Failure. 2005. p. 339–348.
Journal cover image

DOI

ISBN

9781841843742

Publication Date

January 1, 2005

Start / End Page

339 / 348